JP Morgan Maintains Neutral on Solid Biosciences, Lowers Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Anupam Rama maintains a Neutral rating on Solid Biosciences (NASDAQ:SLDB) but lowers the price target from $12 to $10.
May 31, 2024 | 5:18 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
JP Morgan analyst Anupam Rama maintains a Neutral rating on Solid Biosciences (NASDAQ:SLDB) but lowers the price target from $12 to $10.
The lowered price target from $12 to $10 by JP Morgan suggests a less optimistic outlook for Solid Biosciences, which could negatively impact investor sentiment and short-term stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100